ADAM29 and breast carcinoma: In this regard, sequence alterations of the non-catalytic ADAM29 have been described in human melanoma, affecting the adhesion of melanoma cells in vitro.10 Moreover, both ADAM29 mutations and changes in its expression levels were related to other types of human cancer, such as esophageal, gastric, colorectal, renal, and breast cancers.11